EU/3/06/428 - orphan designation for treatment of cutaneous T-cell lymphomaDate of designation: 29 January 2007PositiveLast updated: 21 May 2019OrphanHuman
EU/3/06/421 - orphan designation for treatment of acute lymphoblastic leukaemiaDate of designation: 18 December 2006PositiveLast updated: 21 May 2019OrphanHuman
EU/3/14/1394 - orphan designation for treatment of pancreatic cancerDate of designation: 16 December 2014PositiveLast updated: 22 February 2019OrphanHuman
EU/3/15/1460 - orphan designation for treatment of hepatocellular carcinomaDate of designation: 19 March 2015WithdrawnLast updated: 22 October 2018OrphanHuman
EU/3/13/1121 - orphan designation for treatment of papillary thyroid cancerDate of designation: 26 April 2013WithdrawnLast updated: 22 October 2018OrphanHuman
EU/3/13/1119 - orphan designation for treatment of follicular thyroid cancerDate of designation: 26 April 2013WithdrawnLast updated: 22 October 2018OrphanHuman
EU/3/05/341 - orphan designation for treatment of ovarian cancerDate of designation: 23 December 2005PositiveLast updated: 4 October 2018OrphanHuman
EU/3/18/2021 - orphan designation for prevention of haemolytic uraemic syndromeDate of designation: 25 May 2018PositiveLast updated: 24 July 2018OrphanHuman
EU/3/18/2017 - orphan designation for treatment of amyotrophic lateral sclerosisDate of designation: 25 May 2018PositiveLast updated: 24 July 2018OrphanHuman
EU/3/05/293 - orphan designation for treatment of acute lymphoblastic leukaemiaDate of designation: 16 June 2005ExpiredLast updated: 3 October 2017OrphanHuman